Vertex Pharmaceuticals, Inc. (VRTX)
542.50
-6.54
(-1.19%)
USD |
NASDAQ |
Nov 05, 16:00
537.36
-5.14
(-0.95%)
After-Hours: 20:00
Vertex Pharmaceuticals Net Income (TTM) : 3.976B for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.976B |
| June 30, 2026 | 4.405B |
| March 31, 2026 | 4.338B |
| December 31, 2025 | 3.953B |
| September 30, 2025 | 3.675B |
| June 30, 2025 | 3.638B |
| March 31, 2025 | -988.90M |
| December 31, 2024 | -535.60M |
| September 30, 2024 | -479.80M |
| June 30, 2024 | -489.90M |
| March 31, 2024 | 4.019B |
| December 31, 2023 | 3.620B |
| September 30, 2023 | 3.470B |
| June 30, 2023 | 3.365B |
| March 31, 2023 | 3.260B |
| December 31, 2022 | 3.322B |
| September 30, 2022 | 3.273B |
| June 30, 2022 | 3.195B |
| March 31, 2022 | 2.451B |
| December 31, 2021 | 2.342B |
| September 30, 2021 | 2.176B |
| June 30, 2021 | 1.992B |
| March 31, 2021 | 2.762B |
| December 31, 2020 | 2.712B |
| September 30, 2020 | 2.691B |
| Date | Value |
|---|---|
| June 30, 2020 | 2.081B |
| March 31, 2020 | 1.511B |
| December 31, 2019 | 1.177B |
| September 30, 2019 | 2.118B |
| June 30, 2019 | 2.189B |
| March 31, 2019 | 2.128B |
| December 31, 2018 | 2.087B |
| September 30, 2018 | 663.92M |
| June 30, 2018 | 244.22M |
| March 31, 2018 | 69.18M |
| December 31, 2017 | 91.12M |
| September 30, 2017 | 16.78M |
| June 30, 2017 | 268.51M |
| March 31, 2017 | 201.21M |
| December 31, 2016 | -84.03M |
| September 30, 2016 | -188.24M |
| June 30, 2016 | -242.52M |
| March 31, 2016 | -427.36M |
| December 31, 2015 | -589.96M |
| September 30, 2015 | -694.15M |
| June 30, 2015 | -770.33M |
| March 31, 2015 | -708.72M |
| December 31, 2014 | -742.47M |
| September 30, 2014 | -746.38M |
| June 30, 2014 | -705.05M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Gilead Sciences, Inc. | -3.863B |
| Sionna Therapeutics, Inc. | -97.38M |
| Alnylam Pharmaceuticals, Inc. | 2.724B |
| Regeneron Pharmaceuticals, Inc. | 4.817B |
| Amgen, Inc. | 9.391B |